Skip to content
November 9, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
From Resilience to Leadership: The Enduring Legacy of Richard Goldman and the Shanti Project from-resilience-to-leadership-the-enduring-legacy-of-richard-goldman-and-the-shanti-project-9
  • Integrative Oncology and Holistic Care

From Resilience to Leadership: The Enduring Legacy of Richard Goldman and the Shanti Project

Raul Delapena Setiawan October 20, 2026
Introduction: The Architecture of Compassion In the landscape of social services, few organizations have maintained as consistent...
Read More Read more about From Resilience to Leadership: The Enduring Legacy of Richard Goldman and the Shanti Project
Precision Radiotherapy: Redefining the Management of Oligometastatic and Oligoprogressive Breast Cancer precision-radiotherapy-redefining-the-management-of-oligometastatic-and-oligoprogressive-breast-cancer
  • Clinical Oncology Education

Precision Radiotherapy: Redefining the Management of Oligometastatic and Oligoprogressive Breast Cancer

Siti Muinah October 20, 2026
In the landscape of modern oncology, the treatment of breast cancer is undergoing a paradigm shift. As...
Read More Read more about Precision Radiotherapy: Redefining the Management of Oligometastatic and Oligoprogressive Breast Cancer
Navigating the Post-Treatment Horizon: A Two-Part Series on Physical and Emotional Recovery After Breast Cancer navigating-the-post-treatment-horizon-a-two-part-series-on-physical-and-emotional-recovery-after-breast-cancer
  • Psychosocial Support and Mental Health

Navigating the Post-Treatment Horizon: A Two-Part Series on Physical and Emotional Recovery After Breast Cancer

Suro Senen October 20, 2026
The completion of active breast cancer treatment—be it surgery, chemotherapy, radiation, or hormone therapy—is often marked by...
Read More Read more about Navigating the Post-Treatment Horizon: A Two-Part Series on Physical and Emotional Recovery After Breast Cancer
The Patchwork Safety Net: Mapping the Disparities in American Medicaid Coverage the-patchwork-safety-net-mapping-the-disparities-in-american-medicaid-coverage
  • Breast Cancer Legislation and Policy

The Patchwork Safety Net: Mapping the Disparities in American Medicaid Coverage

Siti Muinah October 20, 2026
For millions of Americans, the Medicaid and Children’s Health Insurance Program (CHIP) represent the critical bridge between...
Read More Read more about The Patchwork Safety Net: Mapping the Disparities in American Medicaid Coverage
Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Comprehensive Analysis navigating-the-intersection-of-glp-1-medications-and-breast-cancer-a-comprehensive-analysis-3
  • Survivorship and Post-Treatment

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Comprehensive Analysis

Sagoh October 20, 2026
Written by Douglas Feil, NBCF Chief Program Officer Disclaimer: The information provided in this article is for...
Read More Read more about Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Comprehensive Analysis
A New Era of Leadership: Dr. Lynn A. Damitz Takes the Helm of the American Society of Plastic Surgeons a-new-era-of-leadership-dr-lynn-a-damitz-takes-the-helm-of-the-american-society-of-plastic-surgeons
  • Breast Cancer Surgery and Reconstruction

A New Era of Leadership: Dr. Lynn A. Damitz Takes the Helm of the American Society of Plastic Surgeons

Ali Ikhwan October 20, 2026
HOUSTON — The landscape of global plastic surgery has entered a new chapter. During the American Society...
Read More Read more about A New Era of Leadership: Dr. Lynn A. Damitz Takes the Helm of the American Society of Plastic Surgeons
A Second Chance at Sunlight: Disc Medicine’s Bitopertin Poised for FDA Redemption a-second-chance-at-sunlight-disc-medicines-bitopertin-poised-for-fda-redemption
  • Chemotherapy and Targeted Therapy

A Second Chance at Sunlight: Disc Medicine’s Bitopertin Poised for FDA Redemption

Reynand Wu October 20, 2026
In the high-stakes world of biotechnology, few narratives are as compelling as the journey from regulatory rejection...
Read More Read more about A Second Chance at Sunlight: Disc Medicine’s Bitopertin Poised for FDA Redemption
Roche Deepens Ties with Chinese Biotech: A Strategic Pivot in Cancer Drug Discovery roche-deepens-ties-with-chinese-biotech-a-strategic-pivot-in-cancer-drug-discovery
  • Chemotherapy and Targeted Therapy

Roche Deepens Ties with Chinese Biotech: A Strategic Pivot in Cancer Drug Discovery

Jia Lissa October 20, 2026
In a significant reinforcement of its global oncology pipeline, Roche has entered into a substantial new partnership...
Read More Read more about Roche Deepens Ties with Chinese Biotech: A Strategic Pivot in Cancer Drug Discovery
Turning the Night Teal, Green, and Pink: The Global Fight Against Metastatic Breast Cancer turning-the-night-teal-green-and-pink-the-global-fight-against-metastatic-breast-cancer
  • Metastatic Breast Cancer Research

Turning the Night Teal, Green, and Pink: The Global Fight Against Metastatic Breast Cancer

Siti Muinah October 20, 2026
NEW YORK, NY — As Breast Cancer Awareness Month unfolds across the globe, the familiar sea of...
Read More Read more about Turning the Night Teal, Green, and Pink: The Global Fight Against Metastatic Breast Cancer
Global Health at a Crossroads: The WHO Responds to U.S. Withdrawal and Pandemic-Era Criticisms global-health-at-a-crossroads-the-who-responds-to-u-s-withdrawal-and-pandemic-era-criticisms
  • Global Breast Cancer Awareness

Global Health at a Crossroads: The WHO Responds to U.S. Withdrawal and Pandemic-Era Criticisms

Muslim October 20, 2026
Introduction: The Fracturing of a Historic Partnership The World Health Organization (WHO), the United Nations’ specialized agency...
Read More Read more about Global Health at a Crossroads: The WHO Responds to U.S. Withdrawal and Pandemic-Era Criticisms

Posts pagination

Previous 1 … 84 85 86 87 88 89 90 … 873 Next

Recent Posts

  • Unraveling the Paradox: Breakthrough Study Redefines Immunotherapy for Colorectal Cancer
  • Pregnancy complication indicator for risk of disease
  • Beyond the "Spaghetti": Talus Bio’s Structure-Free Revolution in Drug Discovery
  • A New Dawn in Genomic Medicine: Casgevy Now Available on the NHS for Blood Disorder Patients
  • The Missing Link: Why Your Mid-Back Strength Is the Secret to Longevity

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unraveling-the-paradox-breakthrough-study-redefines-immunotherapy-for-colorectal-cancer
  • Medical Research and Clinical Trials

Unraveling the Paradox: Breakthrough Study Redefines Immunotherapy for Colorectal Cancer

Reynand Wu November 8, 2026
pregnancy-complication-indicator-for-risk-of-disease
  • Medical Research and Clinical Trials

Pregnancy complication indicator for risk of disease

Siti Muinah November 8, 2026
beyond-the-spaghetti-talus-bios-structure-free-revolution-in-drug-discovery
  • Treatment Innovations

Beyond the "Spaghetti": Talus Bio’s Structure-Free Revolution in Drug Discovery

Reynand Wu November 8, 2026
a-new-dawn-in-genomic-medicine-casgevy-now-available-on-the-nhs-for-blood-disorder-patients
  • Genomics and Precision Medicine

A New Dawn in Genomic Medicine: Casgevy Now Available on the NHS for Blood Disorder Patients

Ammar Sabilarrohman November 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.